文献速递消化系统肿瘤

欧洲早发性结直肠癌:疾病负担、机制与卫生系统启示

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.
PubMed 文献 · Eur J Cancer · 2026-06-28

该综述整合欧洲早发性结直肠癌(EOCRC,50岁以下确诊)的流行病学、机制与卫生系统影响,指出其发病率上升且呈现显著区域异质性,与饮食代谢微生物暴露及遗传易感相关。EOCRC以远端肿瘤、侵袭性病理和不同于经典腺瘤-癌序列的分子特征为主,现有50岁以上筛查体系结构性排除该人群,诊断延迟常见。需发展针对50岁以下无症状者的风险适应早检策略并优化有症状者快速通道,同时关注生存者负担。

要点

  • 欧洲EOCRC发病率上升,区域异质性显著,需协调数据收集与比较研究。
  • EOCRC以远端肿瘤、侵袭性病理及非经典腺瘤-癌序列分子特征为主。
  • 现有50岁以上筛查体系排除50岁以下人群,诊断延迟常见,需风险适应早检与快速通道。

核心结论

  • 欧洲EOCRC发病率上升,呈现区域异质性,需协调欧洲行动以统一数据收集并推动转化研究联盟。
  • 应对EOCRC负担需国家层面实施公平、年龄定制的预防、早检和生存者策略,并可参考欧洲共享框架与比较基准。

研究设计与样本

  • 综述整合欧洲EOCRC的流行病学、机制与卫生系统影响,未报告系统检索范围与样本量。

主要发现

  • 欧洲EOCRC流行病学呈现异质性 mosaic,发病率、死亡-发病比和时间趋势存在显著区域差异。
  • EOCRC临床以远端肿瘤位置为主,组织病理学具侵袭性,分子谱常偏离经典腺瘤-癌序列。
  • 现有组织化筛查项目主要校准于50岁及以上人群,结构性排除50岁以下人群,诊断延迟常见。
  • EOCRC生存者负担较晚发性CRC更重,包括长期功能病态、心理社会影响和经济毒性。

关键数值与推荐

  • EOCRC定义为50岁以下确诊的结直肠癌。
  • 现有筛查项目主要校准于50岁及以上人群。

临床怎么用

  • 对50岁以下无症状者发展风险适应的早期检测策略,对有症状者优化快速通道。
  • 关注EOCRC生存者的长期功能病态、心理社会影响和经济毒性。
  • 利用欧洲区域异质性开展比较研究和卫生政策制定。

局限性

  • 综述未报告系统检索范围、纳入研究数量及偏倚评估方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of early-onset colorectal cancer (EOCRC), diagnosed in individuals under 50 years, is rising across Europe, presenting a growing public health challenge distinct from later-onset disease. This review synthesizes the European landscape, revealing a heterogeneous epidemiological mosaic characterized by stark regional disparities in incidence, mortality-to-incidence ratios, and temporal trends. These patterns are shaped by a transitioning continental 'exposome', that is, the cumulative, lifelong integration of dietary, metabolic, and microbial exposures, interacting with genetic susceptibility. Clinically, EOCRC in Europe is defined by a predominance for distal tumor locations, aggressive histopathology, and a molecular profile that frequently diverges from the classic adenoma-carcinoma sequence. Organized screening programs, largely calibrated to individuals aged 50 years and above, structurally exclude this demographic, while diagnostic delays remain frequent, exacerbated by low clinical suspicion in younger adults. We discuss the dual imperative of developing risk-adapted early detection strategies for asymptomatic people under 50, while optimizing fast-track pathways for symptomatic adults under 50. Furthermore, we examine the disproportionate survivorship burden compared to late-onset CRC, which includes long-term functional morbidity, psychosocial impact, and economic toxicity. These heterogeneities in epidemiological parameters across Europe, while a challenge, offer a unique opportunity for comparative research and for informing health policy. Addressing the rising burden of EOCRC requires coordinated European action to harmonize data collection and foster translational research consortia, coupled with nationally implemented, equitable, and age-tailored prevention, early-detection, and survivorship strategies that can be informed by shared European frameworks and comparative benchmarking.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Wankhede D, Rodriguez MJU, Teich F, et al. Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications. Eur J Cancer. 2026. PMID: 42385607. doi:10.1016/j.ejca.2026.116908

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。